DKK1 and neoplasm: Our lab and others have also demonstrated that DKK1 drives the accumulation of suppressive myeloid populations in melanoma, lung carcinoma, prostate cancer and gastric cancer18, 23, 24, 25, 26, 27, ultimately reducing anti-tumor T cell and NK cell responses.